1. Home
  2. AFCG vs LONA Comparison

AFCG vs LONA Comparison

Compare AFCG & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AFC Gamma Inc.

AFCG

AFC Gamma Inc.

N/A

Current Price

$3.53

Market Cap

61.4M

Sector

Real Estate

ML Signal

N/A

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$4.36

Market Cap

71.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AFCG
LONA
Founded
2020
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
71.2M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
AFCG
LONA
Price
$3.53
$4.36
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $17.33
AVG Volume (30 Days)
66.9K
★ 125.6K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
★ 5.56%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.72
N/A
Revenue
★ $24,563,601.00
N/A
Revenue This Year
$1,384.82
N/A
Revenue Next Year
$1.29
N/A
P/E Ratio
$5.03
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.06
$2.21
52 Week High
$4.01
$14.21

Technical Indicators

Market Signals
Indicator
AFCG
LONA
Relative Strength Index (RSI) N/A 24.85
Support Level N/A N/A
Resistance Level N/A $8.77
Average True Range (ATR) 0.00 0.84
MACD 0.00 -0.33
Stochastic Oscillator 0.00 21.11

Price Performance

Historical Comparison
AFCG
LONA

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: